CAIBSH #4420-172052/2015, RIS 04.00.15 (PI: A.O. Zwenger)
South Oncology Cooperative Group - Associazione Italiana di Oncologia Medica

Genetic resistance markers to cisplatin and / or anti-microtubule therapy in locally advanced cervical cancer

The goal of this project is to evaluate the expression of different miRNAs in cervical cancer patients that were included in one of three prospective phase II trials conducted by South Oncology Cooperative Group in the neoadjuvant setting and compare it with group of patients than received cisplatin as standar doses concurrent with pelvic RT

CAIBHS #4420-149816/2014, RIS 06.00.14 (PI: V. Novaro)
Hormonal Carcinogenesis Laboratory, Institute of Biology and Experimental Medicine (IByME- CONICET).

Study of the stromal reaction as prognostic and predictive marker in breast cancer

CAIBSH #4420-119120/2013, RIS 01.00.13 (PI: P.V. Pérez Verdera)
South Oncology Cooperative Group. SISNe Grant for Health Research, call 2012-2013

Prognostic and / or predictive molecular markers in neoadjuvant treatment of rectal cancer

The goals of this project are to correlate the mucins expression and bio-markers of cancer stem cells in rectal cancer patients underwent to radiochemotherapy neoadjuvant treatment.

• Feb 2013
• Grant: SISNe Grant for Health Research, call 2012-2013.

CAIBSH #4420-098081/2012, RIS 04.00.12 (PI: B.A. Leone)
South Oncology Cooperative Group

Study of Capecitabine and Oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer. Phase IV

The goals of this project are evaluate the efficacy of XELOX scheme in Argentine colorectal cancer patients and different tumoral markers, such as ERCC1, as predictive and prognostic factors.

CAIBSH #4420-086067/2011, RIS 62.00.11 (PI: M.V. Croce)
Centre for Basic and Applied Immunological Research (CINIBA)

Molecular markers indicators in skin metastasis of breast cancer

The goal of this project is to evaluate the antigen expression in primary tumor and correlate it with those found in lymph node compromised and in the cutaneous metastasis of the breast cancer patients..

CAIBSH #4420-86075/2011, RIS 63.00.11 (PI: A.O. Zwenger)
South Oncology Cooperative Group. SISNe Grant for Health Research, call 2011-2012

Prognostic and predictive molecular markers in cancer locally advanced cervical

The goal of this project is to correlate different tumoral antigens in primary tumors with the response to several chemotherapy agents such as cisplatin, vinorelbine, docetaxel among other. Also, identify prognostic molecular markers in the neoa djuvant chemotherapy setting and in the standar radiochemotherapy treatment.

• Oct 2011
• Grant: SISNe Grant for Health Research, call 2011-2012.

CAIBSH #4420-66275/2010, RIS 21.00.10 (PI: G. Pallota)
Clinical Oncology Association of Argentina

Study of ERCC1 gene expression in cancer patients with locally advanced cervical cancer in Argentina

PGI 24/B138 (PI: J.E. Perez)
Project of investigation for the Anatomy-Histology course, UNS, Bahía Blanca, Argentina.

Effect of dietary supplementation on colorectal carcinogenesis, identification of molecules involved.

PGI TIR 24/TB03 (PI: J.E. Perez)
Project of investigation for the Anatomy-Histology course, UNS, Bahía Blanca, Argentina.

Biological effects of fluoride in tap water and organic food on carcinogenesis

PGI 24ZB/24 (PI: J.E. Perez)
Project of investigation for the Anatomy-Histology course, UNS, Bahía Blanca, Argentina.

Expressions in the prevention of the carcinogenesis induced by dimetilhydrazine through different types of diets

PGI 24ZB/19 (PI: J.E. Perez)
Project of investigation for the Anatomy-Histology course, UNS, Bahía Blanca, Argentina.

Prevention of the carcinogenesis induced by dimetilhydrazine through different types of diets